Status:
RECRUITING
Quantitative Sensory Testing and Central Sensitization in Endometriosis
Lead Sponsor:
BC Women's Hospital & Health Centre
Collaborating Sponsors:
University of British Columbia
Conditions:
Endometriosis
Pain
Eligibility:
FEMALE
19-49 years
Brief Summary
Endometriosis is a gynecologic condition where there is growth of endometrial-like tissue outside the uterus, leading to severe pelvic pain. Despite conventional treatment, many patients experience pe...
Detailed Description
Purpose: To validate the Central Sensitization Inventory (CSI), the Pain Sensitivity Questionnaire (PSQ), the Douleur Neuropathique 4 (DN4) questionnaire, the painDETECT (PD-Q) questionnaire, the Self...
Eligibility Criteria
Inclusion
- New or re-referral appointment at the BC Women's Centre for Pelvic Pain and Endometriosis.
- Consented to be contacted for future research in the centre data registry (EPPIC NCT02911090; H16-00264).
- Surgically confirmed endometriosis, current imaging diagnosis, or current clinically suspected endometriosis diagnosed at the new or re-referral appointment as coded in the registry.
- 19 to 49 years old.
- Willing and committed to completing six questionnaires about pain.
- QST specific criteria
- • Willing and committed to QST testing.
Exclusion
- Currently pregnant or breastfeeding.
- Post-menopausal.
- Does not speak English - Patients who do not speak English will be excluded to maintain the safety and well-being of the patient, as not understanding the test and process may harm the patient and reduce the validity of the results. We do not have research funding for a translator. Additionally, patients who require a translator are not typically included in the data registry and therefore are unlikely to be in our sample.
- QST specific criteria
- Diabetes or neurological disease predisposing to neuropathic pain.
- Previous laparotomy (i.e. large abdominal incision)
- Physical trauma (ex., surgery, scaring) to heterotropic QST test site(s) (i.e. deltoid muscle in the shoulder, thenar eminence).
Key Trial Info
Start Date :
May 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 31 2026
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT06215937
Start Date
May 1 2024
End Date
January 31 2026
Last Update
August 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
BC Women's Hospital + Health Centre
Vancouver, British Columbia, Canada, V6H 2N9